Financial, nonfinancial and editors' conflicts of interest in high-impact biomedical journals
Financial, nonfinancial and editors' conflicts of interest in high-impact biomedical journals
复制标题
DOI：
10.1111/eci.12090
复制
发表时间：
2013-07-01
影响因子：
5.5
通讯作者：
Doti, Pamela
中科院分区：
文献类型：
--
作者：
Bosch, Xavier;Pericas, Juan M.;Doti, Pamela
目的评估发表原创性研究的最有影响力的生物医学期刊的财务、非财务和编辑利益冲突（COI）披露政策。材料与方法：我们进行了一项横断面研究，在2011年12月的期刊引文报告（JCR）的27个生物医学类别的399个高影响力的生物医学期刊。收集了期刊网站上公开的与COI和披露要求相关的信息。结果358种（89种中心点7%）期刊要求披露财务COI，280种（70种中心点2%）期刊要求披露非财务COI，155种（38种中心点8%）期刊要求披露编辑COI。在JCR分类的第一个十分位的期刊得分显着高于第二个十分位的所有披露政策。Elsevier出版了90种期刊（22种中心点6%），Wiley-Blackwell出版了59种期刊（14种中心点8%），Elsevier在财务披露政策方面得分明显更高（P=0中心点022）。临床期刊的所有披露政策得分显着高于基础期刊。在开放获取（n=25）和非开放获取（n=374）期刊之间没有观察到任何类型的披露差异。有些不连贯的是，作者的披露声明被包括在57个中心点1%的期刊中的一些已发表的手稿中，而没有任何COI披露政策。结论：约90%发表原创性研究的高影响力临床和基础期刊要求作者披露财务COI。最近的研究显示，与财务披露相比，非财务披露的流行率要低得多，但约70%的期刊要求前者，这表明编辑越来越关注非财务竞争利益。只有40%的期刊要求披露编辑的COI，这与最有影响力的编辑协会的建议相冲突。
Purpose To assess financial, nonfinancial and editors' conflicts of interest (COI) disclosure policies among the most influential biomedical journals publishing original research. Materials and methods We conducted a cross-sectional study of 399 high-impact biomedical journals in 27 biomedical categories of the Journal Citation Reports (JCR) in December 2011. Information relevant to COI and requirements for disclosures that was publicly available on journal websites was collected. Results While financial COI disclosures were required by 358 (89 center dot 7%) and nonfinancial by 280 (70 center dot 2%) journals, 155 (38 center dot 8%) required editors' disclosures. Journals in the first decile of the JCR classification scored significantly higher than those in the second decile for all disclosure policies. Ninety (22 center dot 6%) journals were published by Elsevier and 59 (14 center dot 8%) by Wiley-Blackwell, with Elsevier scoring significantly better in financial disclosure policies (P=0 center dot 022). Clinical journals scored significantly higher than basic journals for all disclosure policies. No differences were observed between open-access (n=25) and nonopen-access (n=374) journals for any type of disclosure. Somewhat incoherently, authors' disclosure statements were included in some published manuscript in 57 center dot 1% of journals without any COI disclosure policies. Conclusions Authors' financial COI disclosures were required by about 90% of high-impact clinical and basic journals publishing original research. Unlike recent studies showing a significantly lower prevalence of nonfinancial compared with financial disclosures, the former were required by about 70% of journals, suggesting that editors are increasingly concerned about nonfinancial competing interests. Only 40% of journals required disclosure of editors' COI, in conflict with the recommendations of the most influential editors' associations.